Management Practicalities

Giuseppe SaglioChair:
Professor Giuseppe Saglio (Italy)

Dr Mohammed YassinCo-chair:
Professor Mohammed Yassin (Qatar)

Overview

“Welcome to the latest Knowledge Centre module – Management Practicalities.           This rich and detailed module will be rolled out in two tranches, starting with the following five topics. Release dates for further material will be announced in the      iCMLf Newsletter. We hope you enjoy these presentations and welcome your questions and comments using the Discussion section link below”.

Nicola Evans, iCMLf Chief Executive

Managing intolerances – Perspectives from the real world

Dr Massimo Breccia

Dr Massimo Breccia

Az. Policlinico Umberto I
Sapienza University
Rome, Italy

Managing comorbidities – Hepatitis B reactivation

Dr Mohammed Yassin

Dr Mohamed A Yassin

Senior Consultant Hematologist, NCCCR
Associate Professor of Medicine, CMED-QU
Doha, Qatar

Managing comorbidities – Managing obesity

Dr Mohammed Yassin

Dr Mohamed A Yassin

Senior Consultant Hematologist, NCCCR
Associate Professor of Medicine, CMED-QU
Doha, Qatar

Managing Comorbidities – Association of Tuberculosis in Patients with CML

Dr Mohammed Yassin

Dr Mohamed A Yassin

Senior Consultant Hematologist, NCCCR
Associate Professor of Medicine, CMED-QU
Doha, Qatar

Managing comorbidities – Opthalmologic manifestations

Dr Mohammed Yassin

Dr Mohamed A Yassin

Senior Consultant Hematologist, NCCCR
Associate Professor of Medicine, CMED-QU
Doha, Qatar

TKI Interactions with Concomitant Medication

Dr Katerina Machova Polakova

Dr Katerina Machova Polakova

Institute of Hematology and Blood Transfusion and
1st Faculty of Medicine,
Charles University
Prague, Czech Republic

Nature and Incidence of Adverse Events

Dr Valentin Garcia Gutierrez

Dr Valentín García Gutiérrez

Department of Hematology and Hematherapy
Hospital Universitario Ramón y Cajal
Universidad de Alcalá
Madrid, Spain

Generic TKIs - Giving your patient the most effective and safe usage

Jeff Lipton

Dr Jeff Lipton

University of Toronto and
Princess Margaret Cancer Centre
Toronto, Canada

When to Consider Allogenic Transplantation in CML

Dr Jerry Radich

Dr Jerry Radich

Clinical Research Division
Kurt Enslein Endowed Chair
Fred Hutch
Seattle, USA

Discussion

Do you have any questions, or comments for the speakers, or community?
Leave your comments below and we will contact the presenter for a reply.

To prevent spam all comments will be forwarded to an admin who will approve the comments and arrange a reply if appropriate.

Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments